Costantine Albany

  • 381 Citations
  • 11 h-Index
20082018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Germ Cell and Embryonal Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Survival Medicine & Life Sciences
Testicular Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2008 2018

1 Citations

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

Rosenberg, J. E., Hahn, N. M., Regan, M. M., Werner, L., Alva, A., George, S., Picus, J., Alter, R., Balar, A., Hoffman-Censits, J., Grivas, P., Lauer, R., Guancial, E. A., Hoimes, C., Sonpavde, G., Albany, C., Stein, M. N., Breen, T., Jacobs, C., Anderson, K. & 4 othersBellmunt, J., Lalani, A. K. A., Pal, S. & Choueiri, T. K., May 1 2018, In : British Journal of Cancer. 118, 11, p. 1434-1441 8 p.

Research output: Contribution to journalArticle

docetaxel
Platinum
Carcinoma
Survival
Antisense Oligonucleotides

Commentary on “Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy.”

Thomas, D. E., Kaimakliotis, H., Rice, K. R., Pereira, J. A., Johnston, P., Moore, M. L., Reed, A., Cregar, D. M., Franklin, C., Loman, R. L., Koch, M., Bihrle, R., Foster, R., Masterson, T., Gardner, T. A., Sundaram, C., Powell, C., Beck, S. D. W., Grignon, D., Cheng, L. & 2 othersAlbany, C. & Hahn, N. M., Jan 1 2018, (Accepted/In press) In : Urologic Oncology: Seminars and Original Investigations.

Research output: Contribution to journalArticle

Carcinoma in Situ
Carcinoma
Drug Therapy
Muscles
Urinary Bladder Neoplasms

Current medical management of patients with poor-risk metastatic germ-cell tumors

Albany, C., Jan 1 2018, In : Current Opinion in Urology. 28, 5, p. 474-478 5 p.

Research output: Contribution to journalReview article

Germ Cell and Embryonal Neoplasms
Etoposide
Cisplatin
Ifosfamide
Bleomycin

Germ Cell Tumors: Updates on Epidemiology, Biology, and Treatment Considerations

Bagrodia, A., Albany, C. & Masterson, T., Jan 1 2018, In : Advances in Urology. 2018, 4821084.

Research output: Contribution to journalEditorial

Germ Cell and Embryonal Neoplasms
Epidemiology
1 Citations

Intermediate prognosis in metastatic germ cell tumours—outcome and prognostic factors

Seidel, C., Daugaard, G., Tryakin, A., Necchi, A., Cohn Cedermark, G., Ståhl, O., Hentrich, M., Brito, M., Albany, C., Taza, F., Gerl, A., Oechsle, K. & Bokemeyer, C., May 1 2018, In : European Journal of Cancer. 94, p. 16-25 10 p.

Research output: Contribution to journalArticle

Germ Cell and Embryonal Neoplasms
Survival Rate
alpha-Fetoproteins
L-Lactate Dehydrogenase
Drug Therapy